Chikungunya virus infection in a patient with Myasthenia gravis: A case report of lethal meningoencephalitis associated with high viral load.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Neuroimmunology Reports
Abstract
Chikungunya virus (CHIKV) is a reemerging arbovirus. Besides its classical acute symptoms, rare
complications such as myocarditis, hepatitis, Guillain-Barré syndrome, encephalitis and meningoencephalitis are
being increasingly reported worldwide
Case presentation: In the present study, we report a case of lethal encephalitis caused by CHIKV associated with
high viral load in an immunosuppressed patient
Case report: A 45-year-old woman with medical history of Myasthenia gravis had onset of fever (Day 1), fol lowed by skin rash and polyarthralgia of large joints. Headache and lethargy started on Day 4. On Day 7, she
was hospitalized, and four days later she developed neurological deterioration, being transferred to the Intensive
Care Unit. Analysis of cerebrospinal fluid (CSF) suggested viral meningoencephalitis. The first CT-scan showed
no significant findings, but real time quantitative PCR was positive for CHIKV in CSF with high viral load. About
24 h after the first CT-scan, brain edema was evident on the second CT-scan. On Day 26, the patient presented
progressive deterioration of brain activity and died. Few other cases of patients presenting neurological compli cations associated with CHIKV were reported in Brazil already, including a patient with Myasthenia gravis and
myelitis due to CHIKV
Conclusions: These cases suggest such autoimmune disorder may favor CHIKV invasion of nervous system. The
present case points out the potential relation of immunosuppressive conditions and severe neurological disease
caused by CHIKV infection.
Description
p. 1-3.: il. p&b.
Citation
URUÇU, Lorena Martel et al. Chikungunya virus infection in a patient with Myasthenia gravis: A case report of lethal meningoencephalitis associated with high viral load. Neuroimmunology Reports, v. 2, p. 1-3, 2022.